参考文献

［1］TEEDE HJ，MISSO ML，BOYLE JA，et al.Translation and implementation of the Australian-led PCOS guideline:clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.Medical Journal of Australia，2018，209（7）:S3-23.

［2］AGNES，A.The importance of restoring body fat mass in the treatment of anorexia nervosa:an expert commentary.J Popul Ther Clin Pharmacol，2019，26（3）:e9-e13.

［3］GORDON CM，ACKERMAN KE，BERGA SL，et al.Functional hypothalamic amenorrhea:an endocrine society clinical practice guideline.J Clin Endocrinol Metab，2017，102（5）:1413-1439.

［4］Collaborative Group on Hormonal Factors in Breast Cancer.Type and timing of menopausal hormone therapy and breast cancer risk:individual participant meta-analysis of the worldwide epidemiological evidence.Lancet，2019，394（10204）:1159-1168.

［5］TRANOULIS A，LAIOS A，PAMPANOS A，et al.Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea:a systematic review of the literature and a meta-analysis.Fertil Steril，2018，109（4）:708-719.

［6］ALVES ED，BONFÁA LO，PIGATTO GR，et a1.Photobiomodulation can improve ovarian activity in polycystic ovary syndrome-induced rats.J Photochem Photobiol B，2019，194:6-13.

［7］LIZNEVA D，SUTURINA L，WALKER W，et al.Criteria，prevalence，and phenotypes of polycystic ovary syndrome.Fertil Steril，2016，106（1）:6-15.

［8］潘烨 ，王泽 ，冯海英 ，等 .来曲唑促排卵研究进展 .中国实用妇科与产科杂志 ，2018，34（3）:340-343.

［9］李萌，阮祥燕.多囊卵巢综合征的诊断治疗与管理.中国医刊，2018，53（5）:465-468.

［10］杨绍玲，李鸿.促性腺激素释放激素脉冲泵治疗的应用及进展.国际内分泌代谢杂志 ，2018，38（2）:124-127.

［11］胡淑敏　，冷义福 ，牟琳琳 ，等 .生长激素在薄型子宫内膜患者冻融胚胎移植周期内膜准备中应用的临床研究.中华生殖与避孕杂志 ，2019，39（12）:963-967.

［12］ROSENFIELD RL，EHRMANN DA.The Pathogenesis of Polycystic Ovary Syndrome（PCOS）:The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Endocr Rev，2016，37（5）:467-520.

［13］FENG Q，GAO B，HUANG H，et al.Growth hormone promotes human endometrial glandular cells proliferation and motion through the GHR-STAT3/5 pathway.Ann Transl Med，2020，8（4）:53.

［14］CHAPLIN A，CARPÉNÉ C，MERCADER J.Resveratrol，Metabolic Syndrome，and Gut Microbiota.Nutrients，2018，10（11）:1651.